RN7SL263P
|
|
RNA, 7SL, cytoplasmic 263, pseudogene
|
|
189
|
0.496 |
0.808 |
|
0.100 |
None
|
0.893 |
28
|
0
|
2011 |
2019 |
Entrez Id: |
3439 |
Gene Symbol: |
IFNA1 |
IFNA1
|
P01562
|
interferon alpha 1
|
|
662
|
0.371 |
0.923 |
|
0.080 |
None
|
1.000 |
8
|
0
|
2011 |
2017 |
Entrez Id: |
3447 |
Gene Symbol: |
IFNA13 |
IFNA13
|
P01562
|
interferon alpha 13
|
|
646
|
0.374 |
0.923 |
|
0.080 |
None
|
1.000 |
8
|
0
|
2011 |
2017 |
Entrez Id: |
3440 |
Gene Symbol: |
IFNA2 |
IFNA2
|
P01563
|
interferon alpha 2
|
|
355
|
0.442 |
0.885 |
|
0.320 |
None
|
1.000 |
7
|
0
|
1991 |
2012 |
Entrez Id: |
28 |
Gene Symbol: |
ABO |
ABO
|
P16442
|
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase
|
Enzyme
|
443
|
0.427 |
0.885 |
|
0.050 |
None
|
1.000 |
5
|
0
|
2008 |
2017 |
Entrez Id: |
260431 |
Gene Symbol: |
COPD |
COPD
|
|
Pulmonary disease, chronic obstructive, severe early-onset
|
|
349
|
0.456 |
0.885 |
|
0.040 |
None
|
1.000 |
4
|
0
|
2017 |
2018 |
Entrez Id: |
2630 |
Gene Symbol: |
GBAP1 |
GBAP1
|
|
glucosylceramidase beta pseudogene 1
|
|
64
|
0.623 |
0.538 |
|
0.030 |
None
|
1.000 |
3
|
0
|
2004 |
2017 |
Entrez Id: |
406936 |
Gene Symbol: |
MIR144 |
MIR144
|
|
microRNA 144
|
|
175
|
0.500 |
0.769 |
|
0.030 |
None
|
1.000 |
3
|
0
|
2010 |
2019 |
Entrez Id: |
7055 |
Gene Symbol: |
THAS |
THAS
|
|
thoracoabdominal syndrome
|
|
120
|
0.560 |
0.808 |
|
0.030 |
None
|
1.000 |
3
|
0
|
2012 |
2018 |
Entrez Id: |
100616444 |
Gene Symbol: |
ERVK-20 |
ERVK-20
|
|
endogenous retrovirus group K member 20
|
|
143
|
0.533 |
0.692 |
|
0.020 |
None
|
1.000 |
2
|
0
|
1991 |
1999 |
Entrez Id: |
192142 |
Gene Symbol: |
RLS1 |
RLS1
|
|
Restless legs syndrome, susceptibility to
|
|
37
|
0.705 |
0.423 |
|
0.020 |
None
|
1.000 |
2
|
0
|
2017 |
2018 |
Entrez Id: |
30816 |
Gene Symbol: |
ERVW-1 |
ERVW-1
|
Q9UQF0
|
endogenous retrovirus group W member 1, envelope
|
|
193
|
0.505 |
0.692 |
|
0.020 |
None
|
1.000 |
2
|
0
|
1991 |
1999 |
Entrez Id: |
317716 |
Gene Symbol: |
BPIFA4P |
BPIFA4P
|
Q86YQ2
|
BPI fold containing family A member 4, pseudogene
|
|
32
|
0.711 |
0.654 |
|
0.020 |
None
|
1.000 |
2
|
0
|
1984 |
2016 |
Entrez Id: |
406938 |
Gene Symbol: |
MIR146A |
MIR146A
|
|
microRNA 146a
|
|
505
|
0.398 |
0.885 |
|
0.020 |
None
|
1.000 |
2
|
0
|
2014 |
2018 |
Entrez Id: |
64006 |
Gene Symbol: |
ERVK-6 |
ERVK-6
|
|
endogenous retrovirus group K member 6, envelope
|
|
162
|
0.521 |
0.808 |
|
0.020 |
None
|
1.000 |
2
|
0
|
1991 |
1999 |
LOH19CR1
|
|
loss of heterozygosity, 19, chromosomal region 1
|
|
96
|
0.569 |
0.808 |
|
0.020 |
None
|
1.000 |
2
|
0
|
2017 |
2019 |
Entrez Id: |
100124696 |
Gene Symbol: |
TEC |
TEC
|
|
transient erythroblastopenia of childhood
|
|
40
|
0.659 |
0.577 |
|
0.010 |
None
|
1.000 |
1
|
0
|
1997 |
1997 |
C20orf181
|
|
chromosome 20 open reading frame 181
|
|
246
|
0.479 |
0.885 |
|
0.010 |
None
|
1.000 |
1
|
0
|
2019 |
2019 |
Entrez Id: |
100287171 |
Gene Symbol: |
WASHC1 |
WASHC1
|
A8K0Z3
|
WASH complex subunit 1
|
|
18
|
0.780 |
0.308 |
|
0.010 |
None
|
1.000 |
1
|
0
|
2019 |
2019 |
Entrez Id: |
100653366 |
Gene Symbol: |
PSC |
PSC
|
|
Cholangitis, primary sclerosing
|
|
67
|
0.603 |
0.731 |
|
0.010 |
None
|
1.000 |
1
|
0
|
2019 |
2019 |
Entrez Id: |
100750225 |
Gene Symbol: |
PCAT1 |
PCAT1
|
|
prostate cancer associated transcript 1
|
|
90
|
0.575 |
0.615 |
|
0.010 |
None
|
1.000 |
1
|
0
|
2014 |
2014 |
Entrez Id: |
101180976 |
Gene Symbol: |
IFNL4 |
IFNL4
|
K9M1U5
|
interferon lambda 4 (gene/pseudogene)
|
|
39
|
0.670 |
0.577 |
|
0.010 |
None
|
1.000 |
1
|
1
|
2020 |
2020 |
LINC01152
|
|
long intergenic non-protein coding RNA 1152
|
|
18
|
0.729 |
0.231 |
|
0.010 |
None
|
1.000 |
1
|
0
|
1990 |
1990 |
LOC102723407
|
|
immunoglobulin heavy variable 4-38-2-like
|
|
159
|
0.514 |
0.769 |
|
0.010 |
None
|
1.000 |
1
|
0
|
2012 |
2012 |
LOC102724971
|
|
putative V-set and immunoglobulin domain-containing-like protein IGHV4OR15-8
|
|
139
|
0.527 |
0.769 |
|
0.010 |
None
|
1.000 |
1
|
0
|
2012 |
2012 |